Interaction between Alzheimer's disease βA4 precursor protein (APP) and the extracellular matrix: Evidence for the participation of heparan sulfate proteoglycans

Journal of Cellular Biochemistry

Volumn 65, Issue 2, 1997, Pages 145-158

  Cáceres, Jorge ^a   Brandan, Enrique ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

amyloid; Alzheimer's disease; extracellular matrix; heparan sulfate proteoglycans

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CHONDROITIN SULFATE; COLLAGEN TYPE 4; FIBRONECTIN; HEPARIN; HEPARIN BINDING PROTEIN; LAMININ; MATRIGEL; PROTEOHEPARAN SULFATE;

ALZHEIMER DISEASE; ARTICLE; BINDING SITE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; PRIORITY JOURNAL; PROTEIN INTERACTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; BINDING SITES; BINDING, COMPETITIVE; COLLAGEN; DRUG COMBINATIONS; EXTRACELLULAR MATRIX; FIBRONECTINS; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; HUMANS; HYDROGEN-ION CONCENTRATION; IODINE RADIOISOTOPES; KINETICS; LAMININ; POLYSACCHARIDE-LYASES; PROTEOGLYCANS;

EID: 1842364870     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(199705)65:2<145::AID-JCB2>3.0.CO;2-U     Document Type: Article

References (45)

1. Adams JC, Watt FM (1993): Regulation of development and differentiation by extracellular matrix. Development 117: 1183-1198.
2. Boudreau N, Sympson CJ, Werb Z, Bissell MJ (1995): Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267:891-893.
3. Brandan E, Inestrosa NC (1993): Extracellular matrix components and amyloid in neuritic plaques of Alzheimer's disease. Gen Pharmacol 24:1063-1068.
4. Breen KC, Bruce M, Anderton BH (1991): Beta amyloid precursor protein mediates neuronal cell-cell and cell-surface adhesion. J Neurosci Res 28:190-100.
5. Breen KC (1986): APP-collagen interaction is mediated by a heparin bridge mechanism. Mol Chem Neuropathol 16: 109-121.
6. Brunden KR, Richter-Cook NJ, Chaturvedi N, Frederickson RCA (1993): pH-dependent binding of synthetic β-amyloid peptides to glycosaminoglycans. J Neurochem 61:2147-2154.
7. Cardin AD, Weintraub HJR (1989): Molecular modeling of protein-glycosaminoglycans interaction. Arteriosclerosis 9:21-32.
8. Carlson SS, Wight TN (1987): Nerve terminal anchorage protein 1 (TAP-1) is a chondroitin sulfate proteoglycan. Biochemical and electron microscopic characterization. J Cell Biol 105:3075-3086.
9. Carpenter G, Cohen S (1976): 1251-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts. J Cell Biol 71:159-171.
10. Glenner GG, Wong CW (1984): Alzheimer's disease: Initial report of the purification of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890.
11. Goldgaber D, Lerman MI, McBride OW, Saffiotti U, Gajdusek DC (1987): Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 235:877-880.
12. Horiguchi Y, Fine JD, Leigh IM, Yoshiki T, Ueda M, Imamura S (1992): Lamina densa malformation involved in histogenesis of primary localized cutaneous amyloidosis. J Invest Dermatol 99:12-18.
13. Iozzo RV, Cohen IR, Murdoch AD (1994): The biology of perlecan: The multifaceted heparan sulfate proteoglycan of basement membranes and pericellular matrices. Biochem J 302:625-639.
14. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Master CL, Grzeschik KH, Multhaup G, Beyreuther K, Muller-Hill B (1987): The precursor of Alzheimer's disease amyloid A4 resembles a cell-surface receptor. Nature 331:530-532.
15. Kleinman HK, McGarvey ML, Liotta LA, Robet PG, Tryggvason K, Martin GR (1982): Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry 21:6188-6193.
16. Klier FG, Cole C, Stallcup W, Schubert D (1990): Amyloid β-protein precursor is associated with extracellular matrix. Brain Res 515:336-342.
17. Lin CQ, Bissell MJ (1993): Multi-faceted regulation of cell differentiation by extracellular matrix. FASEB J 7:737-743.
18. Master CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985): Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82:4245-4249.
19. Mönning U, König G, Banati RB, Mechler H, Czech C, Gehrmann J, Schreiter-Gasser U, Masters CL, Beyreuther K (1992): Alzheimer beta A4-amyloid protein precursor in immunocompetent cells. J Biol Chem 267:23950-23956.
20. Mooradian AD (1988): Effects of aging on blood brain barrier. Neurobiol Aging 9:31-39.
21. Narindrasorasak S, Lowery D, Gonzalez-DeWhitt P, Poorman RA, Greenberg B, Kisilevsky R (1991): High affinity interactions between the Alzheimer's beta-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan. J Biol Chem 266:12878-12883.
22. Narindrasorasak S, Lowery DE, Altman RA, Gonzalez-DeWhitt PA, Greenberg BD, Kisilevsky R (1992): Characterization of high affinity binding between laminin and Alzheimer's disease amyloid precursor proteins. Lab Invest 67:643-652.
23. Narindrasorasak S, Altman RA, Gonzalez-DeWhitt P, Greenberg BD, Kisilevsky R (1995): An interaction between basement membrane and Alzheimer amyloid precursor proteins suggest a role in the pathogenesis of Alzheimer's disease. Lab Invest 72:272-282.
24. Palmert MR, Podlisny MB, Witker DS, Oltersdorf T, Younkin LH, Selkoe DJ, Youkin SG (1989): The β-amyloid protein precursor of Alzheimer's disease has soluble derivatives found in human brain and cerobroespinal fluid. Proc Natl Acad Sci USA 86:6338-6342.
25. Pelmutter LS, Chui HC, Saperia D, Athanikar J (1990): Microangiopathy and the localization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease. Brain Res 508:13-19.
26. Roskelley CD, Srebrow A, Bissell MA (1995): Hierarchy of ECM-mediated signalling regulates tissue-specific gene expression. Curr Opin Cell Biol 7:736-748.
27. Ruoslahti E (1988): Fibronectin and its receptors. Annu Rev Biochem 57:375-413.
28. Schubert D, LaCorbiere M, Saitoh T, Cole G (1989): Characterization of an amyloid B precursor proteins that binds heparin and contains tyrosine sulfate. Proc Natl Acad Sci USA 86:2066-2069.
29. Schultz RT, Pintha J (1985): Relation of the hepatic and splenic microcirculations to the development of lesions in experimental amyloidosis. Am J Pathol 119:127-137.
30. Schultz RT, Pintha JV, McDonald T, Debault LE (1985): Ultrastructural studies of vascular lesions in experimental amyloidosis in mice. Am J Pathol 119:138-150.
31. Sisodia SS, Koo EH, Beyreuther K, Unterbeck A, Price DL (1990): Evidence that beta-amyloid protein in Alzheimer disease is not derived from normal processing. Science 248:363-369.
32. Small DH, Moir RD, Fuller SJ, Michaelson S, Bush AI, Li QX, Milward E, Hilbich C, Weidemann A, Beyreuther K, Masters CL (1991): A protease activity associated with acetylcholinesterase releases the membrane-bound form of the amyloid protein precursor of Alzheimer's disease. Biochemistry 30:10795-10799.
33. Small DH, Nurcombe V, Reed G, Clarris H, Moir R, Beyreuther K, Masters CL (1994): Aheparin-binding domain in the amyloid protein precursor of Alzheimer's disease is involved in the regulation of neurite outgrowth. J Neurosci 14:2117-2127.
34. Snow AD, Willmer J, Kisilevsky R (1987): Sulfated glycosaminoglycans: A common constituent of all amyloid? Lab Invest 56:120-123.
35. Snow A, Mar H, Nochlin D, Kimata K, Suzuki S, Hassell J, Wight TN (1988): The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am J Pathol 133:456-463.
36. Snow AD, Mar H, Nochlin D, Sekiguchi RT, Kimata K, Koike Y, Wight TN (1990): Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am J Pathol 137:1253-1270.
37. Snow AD, Sekiguchi R, Nochlin D, Fraser P, Kimata K, Mizutani A, Arai M, Schreier WA, Morgan DG (1994): An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar Aβ-amyloid in rat brain. Neuron 12:219-234.
38. Snow AD, Kinsella MG, Parks E, Sekiguchi RT, Miller JD, Kimata K, Wight T (1995): Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin and Versican) to the beta-amyloid protein of Alzheimer's disease. Arch Biochem Biophys 320:84-95.
39. Tanzi RE, Gusella JF, Watkins PC, Bruns GAP, St. George-Hyslop PH, Van Keuren ML (1988): Amyloid beta protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer locus. Science 235:880-884.
40. Terranova VP, Hujanen ES, Loeb DM, Martin GR, Thornburg L, Glushko V (1986): Use of a reconstituted basement membrane to measure veil invasiveness and select for highly invasive tumor cells. Proc Natl Acad Sci USA 83:465-469.
41. Tryggvason K (1993): The laminin family. Curr Opin Cell Biol 5:877-882.
42. Weidemann A, König G, Bunke D, Fischer P, Salbaum JM, Masters CL, Beyreuther K (1989): Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57:115-126.
43. Yagamuchi H, Yamazaki T, Lemere C, Frosch MP, Selkoe DJ (1992): Beta-amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease: An immunoelectron microscopic study. Am J Pathol 141:249-259.
44. Young ID, Willmer JP, Kisilevsky RI (1989): The ultrastructural localization of sulfated proteoglycans is identical in the amyloids of Alzheimer disease and AA, AL, senile cardiac and medullary carcinoma-associated amyloidosis. Acta Neuropathol 78:202-209.
45. Young ID, Ailles L, Narindrasorasak S, Tan R, Kisilevsky R (1992): Localization of the basement membrane heparan sulfate proteoglycan in islet amyloid deposit in type-II diabetes-mellitus. Arch Pathol Lab Med 116:951-954.